Rafael Mariano de Bitencourt
Overview
Explore the profile of Rafael Mariano de Bitencourt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
da Silva Joaquim L, da Rosa L, Strickert Y, Machado R, Lanzzarin E, Bernardes G, et al.
Behav Brain Res
. 2025 Mar;
485:115521.
PMID: 40043852
Background: Ischemic stroke is a leading cause of death and disability worldwide. Survivors face disability and psychiatric sequelae resulting from ischemia-induced cell death and associated neuroinflammation, and oxidative stress. Herbal...
2.
de Camargo R, Joaquim L, Machado R, de Souza Ramos S, da Rosa L, de Novais Junior L, et al.
Mol Neurobiol
. 2024 Nov;
PMID: 39613951
The psychoactive decoction Ayahuasca (AYA) used for therapeutic and religious purposes by indigenous groups and peoples from Amazonian regions produces anti-inflammatory and neuroprotective effects. Thus, it may be useful to...
3.
Bonfante S, Netto M, de Oliveira Junior A, Mathias K, Machado R, Joaquim L, et al.
Metab Brain Dis
. 2024 Nov;
40(1):1.
PMID: 39535569
Postoperative cognitive dysfunction (POCD), a complication following procedures such as orthopedic surgery, is associated with a worsened prognosis, especially in the elderly population. Several mechanisms have been proposed for communication...
4.
de Novais Junior L, Vicente da Silva T, da Silva L, de Andrade F, da Silva A, Meneguzzo V, et al.
Cannabis Cannabinoid Res
. 2024 Sep;
PMID: 39347620
Mounting evidence suggests that the phytocannabinoid cannabidiol (CBD) holds promise as an antidepressant agent in conditions underlined by inflammation. Full-spectrum CBD extracts might provide greater behavioral efficacy than CBD-only isolates...
5.
Lodetti G, de Bitencourt R, Rico E
Prog Neuropsychopharmacol Biol Psychiatry
. 2024 Aug;
135:111129.
PMID: 39181308
Alcohol is a harmful drug, and reducing its consumption is a significant challenge for users. Furthermore, alcohol dependence is often treatment-resistant, and no completely effective treatment model is available for...
6.
Sepsis compromises post-ischemic stroke neurological recovery and is associated with sex differences
Joaquim L, Steiner B, Farias B, Machado R, Danielski L, Mathias K, et al.
Life Sci
. 2024 May;
349:122721.
PMID: 38754813
Aims: Infection is a complication after stroke and outcomes vary by sex. Thus, we investigated if sepsis affects brain from ischemic stroke and sex involvement. Main Methods: Male and female...
7.
Metzker K, Mathias K, Machado R, Bonfante S, Joaquim L, da Silva M, et al.
CNS Neurol Disord Drug Targets
. 2024 May;
23(12):1499-1515.
PMID: 38712373
Background: In response to inflammation and other stressors, tryptophan is catalyzed by Tryptophan 2,3-Dioxygenase (TDO), which leads to activation of the kynurenine pathway. Sepsis is a serious condition in which...
8.
de Souza K, Engel N, Soares H, Bressan C, Dela Vedova L, da Silva L, et al.
Metab Brain Dis
. 2024 Mar;
39(4):635-648.
PMID: 38429463
Obesity results from an energy imbalance and has been considered an epidemic due to its increasing rates worldwide. It is classified as a low-grade chronic inflammatory disease and has associated...
9.
Gava F, Jaconi De Carli R, Stork S, Danielski L, Bonfante S, Joaquim L, et al.
Brain Res
. 2024 Jan;
1828:148771.
PMID: 38242525
Sepsis is a life-threatening condition induced by a deregulated host response to infection. Post-sepsis injury includes long-term cognitive impairment, whose neurobiological mechanisms and effective treatment remain unknown. The present study...
10.
de Camargo R, de Novais Junior L, da Silva L, Meneguzzo V, Daros G, da Silva M, et al.
Pharmacol Biochem Behav
. 2022 Nov;
221:173492.
PMID: 36379443
Autism spectrum disorder (ASD) is a neurodevelopmental disorder, onset in early childhood and associated with cognitive, social, behavioral, and sensory impairments. The pathophysiology is still unclear, and it is believed...